{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:13:13Z","timestamp":1777605193000,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001821","name":"Vienna Science and Technology Fund","doi-asserted-by":"publisher","award":["LSC17-026"],"award-info":[{"award-number":["LSC17-026"]}],"id":[{"id":"10.13039\/501100001821","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022750","name":"Office of the Vice President for Research, University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019803","name":"Oklahoma State University Center for Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejphar.2023.175854","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T04:46:26Z","timestamp":1686890786000},"page":"175854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Coronaridine congeners induce sedative and anxiolytic-like activity in na\u00efve and stressed\/anxious mice by allosteric mechanisms involving increased GABAA receptor affinity for GABA"],"prefix":"10.1016","volume":"953","author":[{"given":"Hugo R.","family":"Arias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"De Deurwaerd\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Scholze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Hamachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Di Giovanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-2453","authenticated-orcid":false,"given":"Abdeslam","family":"Chagraoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175854_bib1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.pbb.2006.11.019","article-title":"A possible mechanism for anxiolytic and antidepressant effects of alpha- and beta-amyrin from Protium heptaphyllum (Aubl.) March","volume":"85","author":"Arag\u00e3o","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2023.175854_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114993","article-title":"(+)-Catharanthine potentiates the GABA(A) receptor by binding to a transmembrane site at the \u03b2(+)\/\u03b1(-) interface near the TM2-TM3 loop","volume":"199","author":"Arias","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175854_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175454","article-title":"(+)-Catharanthine and (-)-18-methoxycoronaridine induce antidepressant-like activity in mice by differently recruiting serotonergic and norepinephrinergic neurotransmission","author":"Arias","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175854_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175454","article-title":"(+)-Catharanthine and (-)-18-methoxycoronaridine induce antidepressant-like activity in mice by differently recruiting serotonergic and norepinephrinergic neurotransmission","volume":"939","author":"Arias","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175854_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109930","article-title":"Coronaridine congeners potentiate GABA(A) receptors and induce sedative activity in mice in a benzodiazepine-insensitive manner","volume":"101","author":"Arias","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2023.175854_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109930","article-title":"Coronaridine congeners potentiate GABA(A) receptors and induce sedative activity in mice in a benzodiazepine-insensitive manner","volume":"101","author":"Arias","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2023.175854_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.biocel.2017.10.006","article-title":"Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula","volume":"92","author":"Arias","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.175854_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108194","article-title":"Coronaridine congeners decrease neuropathic pain in mice and inhibit \u03b19\u03b110 nicotinic acetylcholine receptors and CaV2.2 channels","volume":"175","author":"Arias","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2023.175854_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biocel.2015.05.015","article-title":"Coronaridine congeners inhibit human \u03b13\u03b24 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites","volume":"65","author":"Arias","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.175854_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1476-5381.1996.tb15253.x","article-title":"Neurochemical and behavioural interactions between ibogaine and nicotine in the rat","volume":"117","author":"Benwell","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175854_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2017.08.019","article-title":"A standardization of the Novelty-Suppressed Feeding Test protocol in rats","volume":"658","author":"Blasco-Serra","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2023.175854_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/jpet.102.042960","article-title":"Deletion of the alpha1 or beta2 subunit of GABAA receptors reduces actions of alcohol and other drugs","volume":"304","author":"Blednov","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2023.175854_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175854_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1369-1600.2010.00251.x","article-title":"Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration","volume":"15","author":"Carnicella","year":"2010","journal-title":"Addiction Biol."},{"key":"10.1016\/j.ejphar.2023.175854_bib15","first-page":"2745","article-title":"High-efficiency transformation of mammalian cells by plasmid DNA","volume":"7","author":"Chen","year":"1987","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.175854_bib16","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175854_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fncel.2014.00119","article-title":"Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives","volume":"8","author":"Deidda","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175854_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2202-8-85","article-title":"New insight into the role of the beta3 subunit of the GABAA-R in development, behavior, body weight regulation, and anesthesia revealed by conditional gene knockout","volume":"8","author":"Ferguson","year":"2007","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejphar.2023.175854_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2011.08.001","article-title":"Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on nicotine self-administration","volume":"669","author":"Glick","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175854_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.seizure.2013.04.015","article-title":"Molecular mechanisms of antiseizure drug activity at GABAA receptors","volume":"22","author":"Greenfield","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.ejphar.2023.175854_bib21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0022-3565(24)29466-0","article-title":"Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action","volume":"298","author":"Huang","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2023.175854_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0149-7634(02)00010-6","article-title":"The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments","volume":"26","author":"Jung","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2023.175854_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbr.2017.05.008","article-title":"Anxiolytic-like effects of noribogaine in zebrafish","volume":"330","author":"Kalueff","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2023.175854_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0091-3057(03)00119-9","article-title":"Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment","volume":"75","author":"Maisonneuve","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2023.175854_bib25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/10799890600920035","article-title":"GABAA receptors in central nervous system disease: anxiety, epilepsy, and insomnia","volume":"26","author":"M\u00f6hler","year":"2006","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.ejphar.2023.175854_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1601-183X.2005.00165.x","article-title":"Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice","volume":"5","author":"Pennanen","year":"2006","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.ejphar.2023.175854_bib27","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1021\/acschemneuro.0c00152","article-title":"A single administration of the atypical psychedelic ibogaine or its metabolite noribogaine induces an antidepressant-like effect in rats","volume":"11","author":"Rodr\u0131guez","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175854_bib28","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1021\/acscentsci.9b00539","article-title":"Construction of a fluorescent screening system of allosteric modulators for the GABA(A) receptor using a turn-on probe","volume":"5","author":"Sakamoto","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejphar.2023.175854_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF02244871","article-title":"Behavioural and pharmacological characterisation of the elevated \"zero-maze\" as an animal model of anxiety","volume":"116","author":"Shepherd","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2023.175854_bib30","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International union of basic and clinical Pharmacology. CVI: GABA(A) receptor subtype- and function-selective ligands: key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2023.175854_bib31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.0022-3042.2001.00682.x","article-title":"Molecular determinants for the action of general anesthetics at recombinant alpha(2)beta(3)gamma(2)gamma-aminobutyric acid(A) receptors","volume":"80","author":"Siegwart","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2023.175854_bib32","doi-asserted-by":"crossref","first-page":"i167","DOI":"10.1093\/bja\/aex369","article-title":"Role of GABAA receptor subtypes in the behavioural effects of intravenous general anaesthetics","volume":"119","author":"Weir","year":"2017","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2023.175854_bib33","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1073\/pnas.91.10.4569","article-title":"The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit","volume":"91","author":"Wingrove","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.175854_bib34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/ALN.0000000000001978","article-title":"Alphaxalone binds in inner transmembrane \u03b2+-\u03b1- interfaces of \u03b11\u03b23\u03b32 \u03b3-aminobutyric acid type A receptors","volume":"128","author":"Ziemba","year":"2018","journal-title":"Anesthesiology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923003655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923003655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:03:05Z","timestamp":1777410185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923003655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":34,"alternative-id":["S0014299923003655"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175854","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronaridine congeners induce sedative and anxiolytic-like activity in na\u00efve and stressed\/anxious mice by allosteric mechanisms involving increased GABAA receptor affinity for GABA","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175854"}}